July 2024: Pharmacy Product News

Clonidine Hydrochloride (Onyda XR)

From: Tris Pharma

Image Credit: Karanov images - stock.adobe.com

The FDA recently approved clonidine hydrochloride as a once-daily oral treatment for attention-deficit/hyperactivity disorder (ADHD), either as a monotherapy or adjunctive therapy to approved central nervous system stimulant medications in pediatric patients aged 6 years and older. The approval marks the first and only liquid nonstimulant ADHD medication approved in the US and the only approved nonstimulant ADHD medication with nighttime dosing. Study findings demonstrated that patients’ ADHD symptoms were significantly decreased during a 12-week clonidine extended-release treatment, with 7 of 22 patients (31.8%) showing a treatment response. Adverse events included somnolence, dizziness, fatigue, insomnia, and night terrors, among others.

For more information: trispharma.com

Iberogast

From: Bayer

Bayer has released Iberogast, a plant-based digestive relief product that aims to relieve indigestion, bloating, heartburn, nausea, gas, constipation, and diarrhea. The product is available in soft gels or liquid drops and is formulated with 6 herbs that are all clinically proven to aid digestive symptoms. The herbs include Iberis amara, German chamomile, caraway, lemon balm, licorice, and peppermint. All of the herbs work together to regulate stomach movement; relieve pain; soothe the nerves in the stomach; relieve cramps, bloating, and gas; and prevent excessive acid production. Adults aged 18 years and older can take 20 drops (1 mL) 3 times daily before or with meals. Iberogast can be found on Amazon and at most major retailers.

For more information: bayer.com

ThermaCare HeatWraps

From: Bridges Consumer Healthcare

ThermaCare HeatWraps offer long-lasting therapeutic heat for patients experiencing back, neck, or menstrual pain. Heat is known to relax muscles and tissues by increasing blood flow, which in turn increases the oxygen and nutrients traveling into affected areas and accelerating healing. However, portable heating options have historically been limited, with heating pads requiring patients to remain near an outlet. ThermaCare HeatWraps now offer patients a portable option, with a patented heat cell technology that generates long-lasting therapeutic heat when the pouch is opened and air activates the heat wrap. Available options include heat wraps for lower back and hip pain, neck and shoulder pain, joints, muscles, and menstrual pain.

For more information: thermacare.com

Edaravone

Compare with: Radicava, Radicava ORS

Manufactured by: Mitsubishi Tanabe Pharma Corporation

Edaravone is used to treat individuals with amyotrophic lateral sclerosis (ALS). The medication is typically administered in treatment cycles, given as an infusion that takes about 60 minutes to complete. However, an oral suspension can also be administered. It is believed to protect neurons by capturing unstable molecules that could damage cells. Abnormal buildup of these molecules is believed to contribute to neurodegeneration in ALS. Some serious adverse effects of edaravone include bronchospasm, a lightheaded feeling, bruising, headache, and problems with balance or walking.

For more information: https://mt-pharma.co.jp/e/